Denosumab and Teriparatide Transitions in Postmenopausal Osteoporosis (The DATA-Switch Study): a Randomised Controlled Trial

BACKGROUND: Unlike most chronic diseases, approved osteoporosis treatments are generally limited to a single drug at a fixed dose and frequency. Nonetheless, no approved therapy is able to restore skeletal integrity in most osteoporotic patients and the long-term use of most osteoporosis drugs remai...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Lancet
Päätekijät: Leder, Benjamin Z., Tsai, Joy N., Uihlein, Alexander V., Wallace, Paul, Lee, Hang, Neer, Robert M., Burnett-Bowie, Sherri-Ann M.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 2015
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4620731/
https://ncbi.nlm.nih.gov/pubmed/26144908
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S0140-6736(15)61120-5
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia